Godswill James Udom

Godswill James Udom


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2023 in Environmental Research
Verified
Journal Article
Closed access
GUGodswill James Udom
Godswill James Udom
CFChiara Frazzoli
Chiara Frazzoli
OEOsazuwa Clinton Ekhator
Osazuwa Clinton Ekhator
AOAmarachi Paschaline Onyena
Amarachi Paschaline Onyena
BBBeatrice Bocca
Beatrice Bocca
OOOrish Ebere Orisakwe
Orish Ebere Orisakwe

6 February 2025 in Environmental Advances
Verified
Journal Article
Open access
GUGodswill James Udom
Godswill James Udom
BTBrian Turyahabwe
Brian Turyahabwe
AAAyodeji Aturamu
Ayodeji Aturamu
OAOmoirri M. Aziakpono
Omoirri M. Aziakpono
RARichard D. Agbana
Richard D. Agbana
OOOrish E. Orisakwe
Orish E. Orisakwe

1 January 2025 in BioMed Research International
Verified
Journal Article
Open access
CGChitra Gupta
Chitra Gupta
GSGirdhar Kumar Sahu
Girdhar Kumar Sahu
ASHISH KUMAR PARASHARASHISH KUMAR PARASHAR
ASHISH KUMAR PARASHAR
KSKalpana Singh
Kalpana Singh
SBSarad Pawar Naik Bukke
Sarad Pawar Naik Bukke
GUGodswill James Udom
Godswill James Udom
Background: Peptic ulcers, caused by factors like Helicobacter pylori infection and NSAID overuse, are often treated with drugs that can have significant downsides. Curcumin, a natural compound with high therapeutic potential, faces challenges due to poor solubility and instability. Innovative delivery systems are key to unlocking curcumin’s full benefits for effective peptic ulcer treatment. Materials and Methods: To address the challenge of curcumin’s limited bioavailability, a novel drug delivery system was developed. The system employed a twofold strategy: enhancing curcumin’s solubility via complexation with methyl‐ β ‐cyclodextrin, and formulating effervescent, gastroretentive tablets composed of hypromellose and gas‐generating agents. This approach is aimed at achieving sustained gastric retention and localized drug release, thereby maximizing curcumin’s therapeutic potential. Results: The formulated tablets exhibited excellent pharmaceutical properties, meeting all required standards for hardness, friability, and drug content. Importantly, the tablets demonstrated rapid flotation in simulated gastric fluid (buoyancy achieved within 20 s) and maintained buoyancy for approximately 16 h, indicating successful gastroretention. In vitro dissolution studies confirmed sustained drug release (73.92% within 9 h) following a quasi‐Fickian diffusion mechanism, as per the Korsmeyer–Peppas model. Conclusions: This study presents a novel approach to enhance peptic ulcer treatment using floating tablets designed to optimize curcumin delivery. These tablets leverage cyclodextrin complexation for enhanced solubility, while their effervescent, gastroretentive properties allow for prolonged gastric residence time and targeted drug release. This strategy shows promise in improving curcumin’s bioavailability and therapeutic efficacy, addressing a significant unmet need in peptic ulcer management.

1 January 2025 in Indian Journal of Pharmacology
Verified
Journal Article
Open access
JOJoseph G. Omole
Joseph G. Omole
GUGodswill James Udom
Godswill James Udom
AAAyodeji Aturamu
Ayodeji Aturamu
RARichard D. Agbana
Richard D. Agbana
OAOmoirri Moses Aziakpono
Omoirri Moses Aziakpono
OYOmoniyi K. Yemitan
Omoniyi K. Yemitan
Export Cardiac glycosides, historically used for managing heart failure and atrial fibrillation, have demonstrated significant pharmacological versatility extending into oncology, virology, and immunotherapy. By targeting Na+/K+-ATPase, these compounds regulate ionic homeostasis and initiate signalosome formation, influencing key pathways such as MAPK/ERK and PI3K/Akt. Beyond their cardiovascular effects, cardiac glycosides exhibit potent immunomodulatory and senolytic properties, particularly in cancer therapy. They induce immunogenic cell death by releasing damage-associated molecular patterns, which enhance tumor antigen presentation and activate cytotoxic T lymphocytes. In addition, their ability to selectively eliminate senescent tumor cells through Na+/K+-ATPase inhibition reduces inflammation and improves therapeutic outcomes in synergistic cancer treatments. Furthermore, their antiviral activities have been explored against SARS-CoV-2 and Ebola virus infections, with mechanisms involving the disruption of viral entry, replication, and protein synthesis. Despite their promise, concerns about cardiotoxicity and a narrow therapeutic window persist, necessitating precise dosing and novel derivatives with improved safety profiles. This review consolidates current insights into the mechanisms, therapeutic applications, and limitations of cardiac glycosides, highlighting their potential as a cornerstone for future drug development in oncology and infectious diseases. Advancing pharmacogenomic approaches and clinical trials will further define their role in precision medicine.

9 July 2025 in Physiological Reports
Verified
Journal Article
Open access
JOJoseph G. Omole
Joseph G. Omole
IOIdara A. Okon
Idara A. Okon
GUGodswill James Udom
Godswill James Udom
OAOmoirri M. Aziakpono
Omoirri M. Aziakpono
RARichard D. Agbana
Richard D. Agbana
OYOmoniyi K. Yemitan
Omoniyi K. Yemitan
The brain–heart connection, particularly during physical activity, plays a crucial role in health and disease management. This review examined the neurophysiological mechanisms driving cardiovascular adaptations to exercise, focusing on the bidirectional relationship between the brain and heart. Key mediators such as central autonomic networks, brain‐derived neurotrophic factors (BDNF), and vascular endothelial growth factor (VEGF) enhance neural plasticity and vascular health. Regular structured exercise (e.g., high‐intensity interval training, moderate and resistance exercise) moderates autonomic responses, increases BDNF, and supports neurovascular coupling, improving both cognitive and cardiovascular resilience through molecular pathways such as PGC‐1α and TrkB signaling. Exercise enhances cerebral perfusion, reduces oxidative stress, and protects brain–heart health. It mitigates risks linked to neurodegenerative diseases, such as Alzheimer's and Parkinson's, by promoting neuroplasticity and vascular integrity. This review highlights the importance of incorporating exercise‐based interventions in clinical practice and public health policies to optimize cognitive and cardiovascular health. Future studies should explore exercise‐induced neurovascular coupling to further elucidate the mechanisms connecting brain and cardiovascular health.

26 September 2025 in Environmental Sciences Europe
Verified
Journal Article
Open access
PDF file
GUGodswill James Udom
Godswill James Udom
NNNicodemus Niwamanya
Nicodemus Niwamanya
OAOmoirri M. Aziakpono
Omoirri M. Aziakpono
NUNita-Wills G. Udom
Nita-Wills G. Udom
HMH. Malathi
H. Malathi
KMKhursheed Muzammil
Khursheed Muzammil
Polycyclic aromatic hydrocarbons (PAHs) are toxic substances formed during the incomplete burning of organic matter, and they pose major threats to human health and the environment. This systematic review assesses the public health burden of PAH exposure in East Africa, focusing on sources, health effects, and mitigation strategies. East Africa is experiencing rapid urbanization, industrial growth, and increasing reliance on biomass fuels, all of which contribute to elevated environmental PAH levels. Despite these developments, the region remains underrepresented in global PAH risk assessments, with limited localized data guiding policy and public health responses. This geographic focus is thus critical to identify context-specific exposure sources, assess the unique vulnerabilities of East African populations, and support targeted mitigation strategies aligned with regional socioeconomic and environmental realities. Using the PRISMA framework, studies were screened for quality and bias via the Newcastle–Ottawa Scale and JBI checklists, with 20 out of 183 articles meeting the inclusion criteria. Key exposure sources include biomass and fossil fuel combustion, urban air pollution, industrial emissions, occupational hazards, and dietary intake. Vulnerable groups, particularly women, children, and low-income urban dwellers, face heightened risks, including the risk of respiratory diseases, cardiovascular disorders, cancer, adverse birth outcomes, and neurodevelopmental impairments. Despite growing concerns, policy gaps, weak enforcement of air quality standards, and limited public awareness hinder effective mitigation. Therefore, urgent interventions are needed, including clean energy adoption, urban air pollution control, industrial regulations, and stronger public health policies. To address PAH exposure in East Africa, a multi-sectoral approach integrating policy reforms, community engagement, and sustainable environmental practices to protect public health is imperative.